Ovarian Failure
19
1
2
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (19)
Ovarian Tissue Allo-transplantation
Study of PRP in Women With Evidence of Diminished Ovarian Reserve
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
MAR With Artificial Gametes: Treatment Characteristics and Their Trade-offs Determining Treatment Preference
Thyroid Function and Autoimmunity in Subfertility Women and Assisted Reproductive Therapy
Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response
Ovarian Rejuvenation Using Platelet Rich Plasma (PRP) & Autologous Tissue Stromal Vascular Fraction (tSVF) and Cell Enriched tSVF
Effects of Ovarian Reserve on Sexual Satisfaction
Uterine Transposition: Feasibility Study
Stem Cell Therapy and Growth Factor Ovarian in Vitro Activation
Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
Ovarian Fragmentation Study (Crespo Medical Team)
Is the Concentration of Anti-Muellerian Hormon (AMH) Depending on the Menstrual Cycle?
Can Celiac Disease Affect Ovarian Function in Adolescent?
Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes
Fertility Preservation With Ovarian Tissue Freezing
Goserelin for Ovarian Protection in Premenopausal Patients Receiving Cyclophosphamide